July 2021
Our July issue celebrates the grand winner of our 2020 Innovation Awards: the Smart Container from Schott which improves visibility into fill and finish processes. Elsewhere in the issue, we cover 3D printing, digital technology, and cyberattacks – in Upfront – and CRISPR-engineered cell therapies, continuous biomanufacturing, and gender diversity – in In My View. We also have articles on the UK’s Vaccine Taskforce, improving clinical trials, and the latest breakthroughs in cell and gene. Finally, we sit down with Sudarshan Jain, Secretary-General of the Indian Pharmaceutical Alliance.
Just Press Print
July 27, 2021
Can decentralized additive manufacturing bring customized medicines to targeted patient groups?
1 min read
The Digital Advantage
July 26, 2021
How can pharma make the most of digital technologies? Experts shared their views at Veeva’s Commercial and Medical Summit
1 min read
People, Process, Product: Lessons Learned with Antoinette Gawin
July 23, 2021
Antoinette Gawin, President and CEO of Terumo Blood and Cell Technologies, explains how a random act of kindness set her on the path to becoming a VP in her 20s. Antoinette shares her lessons learned overcoming adversity to succeed in finance, utilities, M&A and – finally – cell and gene therapy.
1 min read
Supporting Patients During Treatment
July 16, 2021
We speak with Adam Shain, Director Business Development, Digital Healthcare, and Josh Hopkins, Program Manager, AdhereIT from Noble, an Aptar Pharma company, about the AdhereIT 360 Base and AdhereIT Clip - a runner up for The Medicine Maker 2020 Innovation Awards.
1 min read
Boosting Cell Line Expression
July 15, 2021
We speak with Gregory Bleck, Vice President of R&D, Catalent Biologics, and the inventor of the original GPEx and leader of the GPEx Boost technology development team about the GPEx Boost Technology - a runner up for The Medicine Maker 2020 Innovation Awards.
1 min read
COVID-19: Inside the UK's Vaccine Taskforce
July 14, 2021
Hundreds of millions of doses secured, the first approval, and one of the fastest vaccination programs in the world. How did the UK do it?
1 min read
What's New from The Cell + Gene Curator?
July 13, 2021
History made as CAR T comes to China, bad news for Biogen and Tmunity, and the first reported case of partial functional recovery in a neurodegenerative disease after optogenetic therapy… What’s new from the Cell + Gene Curator?
1 min read
Take Care of Yourself!
July 8, 2021
COVID-19, Brexit and the digital challenge – unpacking the unpredictable demand for over-the-counter medicines
1 min read
Future Sight
July 6, 2021
New technology gives manufacturers greater visibility into fill and finish processes than ever before
1 min read
Inclusive Drug Development
July 5, 2021
Gender diversity in pharma: better health for all requires medicines that are made for all
1 min read
Understanding the Three Levels of Genetic Medicine
July 2, 2021
ASC Therapeutics is using a new type of stem cell derived from human placenta to treat graft-versus-host disease, as well as tackling hemophilia with gene and CRISPR therapies. To find out more, we speak with Chief Medical Officer Oscar Segurado, who also stresses the importance of helping patients understand the difference between gene therapy and different kinds of gene editing involving CRISPR.
1 min read
COVID-19’s Digital Legacy
July 1, 2021
Efficient data management is critical to meet the demand for fast drug development – especially today
1 min read
Don’t Break My Strands
June 29, 2021
CRISPR-engineered cell therapies with multiple gene knockouts could be limited by double-strand breaks
1 min read
Continuous: Before you Leap, Consider this
June 28, 2021
There’s a lot of talk about the cost benefits of implementing continuous biomanufacturing, but where is the data?
1 min read
The Human Yin to the Clinical Yang
June 23, 2021
Humanizing clinical trials through patient advocacy
1 min read
Learning Never Stops
June 4, 2021
Sitting Down With… Sudarshan Jain, Secretary-General of the Indian Pharmaceutical Alliance (IPA)
1 min read
Clinical Trials and Tribulations
March 12, 2021
Why isn’t pharma leaning into the digital technologies available to improve clinical trials?
1 min read
